T 0091/22 (PHARMACEUTICAL COMPOSITION CONTAINING AN ANTI-NUCLEATING AGENT/Merck Sharp & Dohme LLC) of 26.03.2024
- European Case Law Identifier
- ECLI:EP:BA:2024:T009122.20240326
- Date of decision
- 26 March 2024
- Case number
- T 0091/22
- Petition for review of
- -
- Application number
- 16198994.2
- IPC class
- A61K 9/48A61K 9/20A61K 31/513
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- PHARMACEUTICAL COMPOSITION CONTAINING AN ANTI-NUCLEATING AGENT
- Applicant name
- Merck Sharp & Dohme LLC
- Opponent name
- Kraus & Lederer PartGmbB
Ter Meer Steinmeister & Partner Patentanwälte mbB - Board
- 3.3.07
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 56European Patent Convention Art 76(1)European Patent Convention R 80Rules of procedure of the Boards of Appeal 2020 Art 012(2)Rules of procedure of the Boards of Appeal 2020 Art 012(4)Rules of procedure of the Boards of Appeal 2020 Art 013(2)
- Keywords
- -
- Catchword
- -
- Cited cases
- T 1742/19
- Citing cases
- T 0072/23
Order
For these reasons it is decided that:
The appeals are dismissed.